• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

Updated: ICH Q12: A Framework for Managing Post-Approval CMC Changes

The US Food and Drug Administration (FDA) made available an International Council for Harmonisation (ICH) draft guidance on technical and regulatory considerations for pharmaceutical lifecycle management.

Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management

Q12 Annex

News & Trends

Procurar

Recentes

  • A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
  • Electronic Submission Template for Premarket Approval Applications (PMAs)
  • MDSAP Technical Review and Recognition Decision Procedure
  • Essential Principles and Content of Predetermined Change Control Plans. Final Document
  • Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
  • GMP and GDP Question and Answer Guide Version 03 published by ECA
  • Guideline on good pharmacovigilance practices (GVP) Module III – Pharmacovigilance inspections (Rev 2)
  • Publication of COMBINE Project 2 Sponsors’ guide on safety reporting in combined studies

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto